Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
about the author
ENDPOINTS
editor@endpointsnews.com
author articles
AstraZeneca hands over opioid addiction pill to Eolas; TandemAI, Perpetual Medicines merge
8 hours ago
News Briefing
Novartis' brain delivery platform option deal worth up to $175M; Neumora's next steps
Yesterday
News Briefing
Recursion takes full rights to rare genetic disorder drug; CStone out-licenses cancer drug in Europe
2 days ago
News Briefing
Denali's Hunter syndrome therapy gets priority review; LENZ inks Canada deal
3 days ago
News Briefing
Cloudbreak’s shares stumble in Hong Kong debut; Sinovac squares off against activist
Last week
News Briefing
Organon stops work on drug once viewed as ‘game-changing’; NextPoint culls an asset
Last week
News Briefing
Broad Institute conducts layoffs as it preps for cuts in federal funding; Dyne’s financing
Last week
News Briefing
INmune Bio’s Alzheimer’s drug fails Phase 2; BridgeBio sells some ATTR-CM royalties
Last week
News Briefing
BioCryst sells Orladeyo business in Europe; UCB gets a Phase 3 win for Fintepla
Last week
News Briefing
Edgewise details pivotal plans in Becker muscular dystrophy; Kymera’s $250M offering
2 weeks ago
News Briefing
Arbutus regains rights to hepatitis B asset in China; Forte’s $75M offering
3 weeks ago
News Briefing
ArriVent plots next steps for lung cancer drug; Neuron23's $96.5M raise
3 weeks ago
News Briefing
Formation Bio’s up to €545M licensing deal with Sanofi; Otsuka, Harbour BioMed team up
3 weeks ago
News Briefing
FDA OKs new label expansions for Dupixent and Incyte's Monjuvi
3 weeks ago
News Briefing
Bavarian Nordic's PRV goes for $160M; Biomea to advance GLP-1 into trials
4 weeks ago
News Briefing
Prothena moves forward with layoffs; Aldeyra resubmits dry eye drug to FDA
4 weeks ago
News Briefing
Incyte’s promising thrombocythemia drug; Crescent Biopharma raises $200M in PIPE
4 weeks ago
News Briefing
Rein Therapeutics study on clinical hold; Beam updates sickle cell therapy data
4 weeks ago
News Briefing
ADC Therapeutics reveals layoffs, $100M PIPE; Third Harmonic seeks buyer for asset
4 weeks ago
News Briefing
Lilly pledges more than $650M to muscle health biotech; Cogent gets $50M
5 weeks ago
News Briefing
Insmed’s stock rallies on PAH data; Unicycive aims to resolve CDMO issues
5 weeks ago
News Briefing
Avidity to seek accelerated approval for FSHD drug; Axsome to run another trial
Last month
News Briefing
Kelun's $250M PIPE; Valneva moves chikungunya vaccine to Phase 3 for kids
Last month
News Briefing
Biopharma leaders carving a path for the industry’s LGBTQ+ community
Last month
People
Special
1
2
3
4
Next page
Last page